Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Zafar

Showing results (101-110 of 114) with videos related to

Pageof 12
Sort By:
JAMA Neurology|September 23, 2024
Antiseizure Medication Use and Outcomes After Suspected or Confirmed Acute Symptomatic SeizuresSahar F Zafar, Adithya Sivaraju, Clio Rubinos, et al.
Neurology. Clinical Practice|November 29, 2024
Barriers to Medication Adherence in People Living With EpilepsyMaria Andrea Donahue, Hammad Akram, Julianne D Brooks, et al.
Annals of Neurology|July 7, 2021
Automated Annotation of Epileptiform Burden and Its Association with OutcomesSahar F Zafar, Eric S Rosenthal, Jin Jing, et al.
Expert Systems with Applications|March 3, 2023
Classification of neurologic outcomes from medical notes using natural language processingMarta B Fernandes, Navid Valizadeh, Haitham S Alabsi, et al.
Annals of Neurology|April 17, 2018
Continuous electroencephalography predicts delayed cerebral ischemia after subarachnoid hemorrhage: A prospective study of diagnostic accuracyEric S Rosenthal, Siddharth Biswal, Sahar F Zafar, et al.
Epileptic Disorders : International Epilepsy Journal with Videotape|June 30, 2022
Measuring expertise in identifying interictal epileptiform dischargesNitish M Harid, Jin Jing, Jacob Hogan, et al.
Haematologica|January 25, 2024
Genomic landscape of patients in a phase II study of zanubrutinib in ibrutinib- and/or acalabrutinib-intolerant patients with B-cell malignanciesLinlin Xu, Mazyar Shadman, Ian W Flinn, et al.
Medrxiv : the Preprint Server for Health Sciences|December 8, 2025
Predicting Post-Traumatic Epilepsy with Automated Contusion Measurements using Acute CT Images: A Competing Risk ApproachB Berke Ayvaz, Justin R Wheelock, Daniel S Jin, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|March 1, 2021
Systemic ventricular assist device support in Fontan patients: A report by ACTIONAri Cedars, Shelby Kutty, David Danford, et al.
The Lancet. Haematology|November 18, 2022
Zanubrutinib in patients with previously treated B-cell malignancies intolerant of previous Bruton tyrosine kinase inhibitors in the USA: a phase 2, open-label, single-arm studyMazyar Shadman, Ian W Flinn, Moshe Y Levy, et al.
Pageof 12

Showing results (101-110 of 114) with videos related to

Sort By:
Pageof 12
JAMA Neurology|September 23, 2024
Antiseizure Medication Use and Outcomes After Suspected or Confirmed Acute Symptomatic SeizuresSahar F Zafar, Adithya Sivaraju, Clio Rubinos, et al.
Neurology. Clinical Practice|November 29, 2024
Barriers to Medication Adherence in People Living With EpilepsyMaria Andrea Donahue, Hammad Akram, Julianne D Brooks, et al.
Annals of Neurology|July 7, 2021
Automated Annotation of Epileptiform Burden and Its Association with OutcomesSahar F Zafar, Eric S Rosenthal, Jin Jing, et al.
Expert Systems with Applications|March 3, 2023
Classification of neurologic outcomes from medical notes using natural language processingMarta B Fernandes, Navid Valizadeh, Haitham S Alabsi, et al.
Annals of Neurology|April 17, 2018
Continuous electroencephalography predicts delayed cerebral ischemia after subarachnoid hemorrhage: A prospective study of diagnostic accuracyEric S Rosenthal, Siddharth Biswal, Sahar F Zafar, et al.
Epileptic Disorders : International Epilepsy Journal with Videotape|June 30, 2022
Measuring expertise in identifying interictal epileptiform dischargesNitish M Harid, Jin Jing, Jacob Hogan, et al.
Haematologica|January 25, 2024
Genomic landscape of patients in a phase II study of zanubrutinib in ibrutinib- and/or acalabrutinib-intolerant patients with B-cell malignanciesLinlin Xu, Mazyar Shadman, Ian W Flinn, et al.
Medrxiv : the Preprint Server for Health Sciences|December 8, 2025
Predicting Post-Traumatic Epilepsy with Automated Contusion Measurements using Acute CT Images: A Competing Risk ApproachB Berke Ayvaz, Justin R Wheelock, Daniel S Jin, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|March 1, 2021
Systemic ventricular assist device support in Fontan patients: A report by ACTIONAri Cedars, Shelby Kutty, David Danford, et al.
The Lancet. Haematology|November 18, 2022
Zanubrutinib in patients with previously treated B-cell malignancies intolerant of previous Bruton tyrosine kinase inhibitors in the USA: a phase 2, open-label, single-arm studyMazyar Shadman, Ian W Flinn, Moshe Y Levy, et al.
Pageof 12